FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Medical Devices

Lab Test Firms, Others Plead Guilty in Kickback Scheme

Eleven defendants, including the founders of several lab companies, plead guilty in a $300 million scheme to pay kickbacks to induce medical professio...

Human Drugs

Gileads Veklury OKd for Covid Pediatric Patients

FDA expands the approval of Gilead Sciences Veklury (remdesivir) to include treating Covid-19 pediatric patients 28 days of age and older weighing at ...

Human Drugs

Ardelyx Gets Panel Review on Tenapanor Appeal

CDERs Office of New Drugs says it will convene its Cardiovascular and Renal Drug Advisory Committee to hear an appeal from Ardelyx of a complete respo...

Federal Register

Latest Federal Register Notices

FDA Review posts the Federal Register notices for the week ending 4/22/2022.

FDA General

Since Our Last Issue ...

Industry news you may have missed since our last issue.

FDA General

Product Approval Summaries

FDA Review posts product approval summaries for the week ending 4/22/2022.

Federal Register

Covid-19 Vaccine Guidance Update

Federal Register notice: FDA makes available an updated guidance document entitled Emergency Use Authorization for Vaccines to Prevent Covid19 (Update...

Medical Devices

Guide on 510(k) Refuse to Accept Policy

FDA posts a final guidance entitled Refuse to Accept Policy for 510(k)s that outlines the procedures and criteria the agency intends to use in assessi...

Human Drugs

Biogen Pulls European Submission on Alzheimers Drug

Biogen withdraws a European marketing authorization application for its troubled Alzheimers drug aducanumab.

Human Drugs

Revance BLA Resubmission Accepted for Review

FDA accepts for review a Revance Therapeutics BLA resubmission for DaxibotulinumtoxinA for Injection, indicated for treating moderate to severe glabel...